entity

clopidogrel

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about clopidogrel: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
1Hypotheses
1Analyses
4Outgoing
0Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (4)

TargetRelationTypeStr
P2Ry12targetsprotein0.95
Acute Coronary Syndrometreatsdisease0.90
Platelet Activationinhibitsprocess0.90
neurodegenerationtherapeutic_target_fordisease0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Pharmacological P2RY12 inhibition (ticagrelor/clopidogrel) a 0.583 neurodegeneration How does P2RY12-mediated VSMC dysfunctio

Mentioning Analyses (1)

Scientific analyses that reference this entity

Can circadian interventions selectively target microglia without affecting other

neuropharmacology | 2026-04-10 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate highlighted a critical cell-type specificity gap where no evidence ex

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Related Research

Hypotheses and analyses mentioning clopidogrel in their description or question text

No additional research found